RBSH (Rebus Hldgs) Short Percentage of Float


What is Rebus Hldgs Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

RBSH vs KRBP, CNBX, EVFM: Short Percentage of Float Comparison

For the Biotechnology subindustry, Rebus Hldgs's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rebus Hldgs Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rebus Hldgs's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Rebus Hldgs's Short Percentage of Float falls into.


Rebus Hldgs Business Description

Address 2629 Townsgate Road, Suite 215, Westlake Village, CA, USA, 91361
Rebus Hldgs Inc is an early-stage, pre-revenue, pharmaceutical company that is focused on the development of prodrug cancer therapeutics for the treatment of disease. The company along with its subsidiaries is engaged in the production of small-molecule adenosine receptor modulators. Adenosine is an extracellular signaling molecule that regulates multiple aspects of tissue function and specifically plays a role in immunity and inflammation.